ClinicalTrials.Veeva

Menu

Comparison of Flat Colorectal Lesion Detection by Artificial Intelligence-assisted Colonoscopy Versus Endoscopists (AIChallengeMed)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Active, not recruiting

Conditions

Flat Colorectal Lesion

Treatments

Procedure: proportion of colorectal lesions

Study type

Observational

Funder types

Other

Identifiers

NCT05942677
69HCL21_1366

Details and patient eligibility

About

The development of artificial intelligence (AI) systems in the field of colorectal endoscopy is currently booming, colorectal cancer being, by its frequency and severity, a real public health problem.

In terms of image analysis, AI is indeed able to perform many tasks simultaneously (lesion detection, classification, and segmentation) and to combine them.

Lesion detection is thus the starting point of the whole chain to choose at the end the most appropriate treatment for the patient. Large-scale studies have demonstrated the superiority of artificial intelligence-assisted detection over the usual detection by gastroenterologists, mainly for the detection of sub-centimeter polyps.

However, the investigators have shown that a recent computer-aided detection system (CADe) such as the ENDO-AID software in combination with the EVIS X1 video column (Olympus, Tokyo, Japan) may present difficulties in the detection of flat lesions such as sessile serrated lesions (SSLs) and non-granular laterally spreading tumors (LST-NGs).

This represents a major challenge because in addition to their shape being difficult to identify for the human eye in practice and where AI assistance would be of great value, these rare lesions are associated with advanced histology.

In addition, the investigators recently described the case of a worrisome false negative of AI-assisted colonoscopy, which failed to detect a flat adenocarcinoma in the transverse colon.

Therefore, it is important to measure the false negative rate of AI detection based on the macroscopic shape of the lesion. Comparing this rate to the human endoscopist's false negatives would improve the performance of AI for this specific lesion subtype in the future.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • both gender patients even or older than 18 years old
  • patient with French Health Insurance coverage
  • obtaining of oral non opposition to research after loyal, clear and complete delivery of information
  • patients addressed to our center for colorectal lesion resection
  • patients presenting a colorectal lesion discovered during a diagnostic colonoscopy

Exclusion criteria

  • patients with health disorders needing short procedure times
  • patients with no colorectal lesion
  • difficulty continuing colonoscopy due to poor sedation
  • difficulty continuing colonoscopy due to a serious adverse event
  • inappropriate participation after colonoscopy is completed
  • unwillingness to participate after colonoscopy is completed

Trial design

160 participants in 1 patient group

Colorectal lesion diagnostic
Description:
Every patient referred to our center for colorectal endoscopy for investigation and/or resection of colorectal lesion can join the cohort of this study and will benefit from diagnosis and treatment by experienced endoscopists.
Treatment:
Procedure: proportion of colorectal lesions

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems